by Suzanne D. Vernon, PhD | Feb 9, 2023 | BHC News, ME/CFS, Research News
Potential Targets for ME/CFS Clinical Trials This week showcased Bateman Horne Center’s strategic plan in action. The new research published in two separate papers in the prestigious journal, Cell Host & Microbe, provided further evidence that the microbiome and...
by Suzanne D. Vernon, PhD | Dec 6, 2022 | BHC News, Long COVID, ME/CFS, Research News
Over the past 5 years, 285 of you have participated in an NIH-funded research study at Bateman Horne Center! This study was led by The Jackson Laboratory (JAX), one of the three ME/CFS Collaborative Research Centers funded by the NIH. BHC was the Clinical Core for JAX...
by Suzanne D. Vernon, PhD | Jul 29, 2022 | BHC News, Long COVID, Research News
There are about 8 different herpes viruses that infect humans – herpes simplex virus types 1 and 2, varicella-zoster virus, cytomegalovirus, Epstein-Barr virus, human herpesvirus 6 (variants A and B), human herpesvirus 7, and Kaposi’s sarcoma virus or...
by Suzanne D. Vernon, PhD | Jul 14, 2022 | BHC News
In February of this year, we began enrolling for a study to evaluate endothelial function in people with ME/CFS and Long COVID. “Endothelial” refers to the cells that line the inside of blood vessels. Endothelial cells are actively involved in contracting/relaxing the...
by Suzanne D. Vernon, PhD | Apr 4, 2022 | BHC News, Long COVID, ME/CFS, Newsletters, Research News
Many investigators pivoted to SARS-CoV-2 and COVID-19 science and medicine in 2020. We did too at BHC because we understood the opportunity the pandemic provided for “real-time” clinical research of post-COVID-19 sequelae and to share all we know about...